Belgium
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -5.52 M
|
Dec. 31, 2023 | USD 23.14 | 1.75% |
|
Belgium |
The Vaccines company in Belgium with the highest Net Cash Used Provided By Financing Activities is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at USD -5.52 M.
The Vaccines company in Belgium with the lowest Net Cash Used Provided By Financing Activities is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at USD -5.52 M.
The top 10 Vaccines companies in Belgium by Net Cash Used Provided By Financing Activities are and Galapagos NV.
The bottom 10 Vaccines companies in Belgium by Net Cash Used Provided By Financing Activities are and Galapagos NV.